Journal of the Korean Academy of Child and Adolescent Psychiatry

Korean Academy of Child and Adolescent Psychiatry (대한소아청소년정신의학회)
권호 표지
DOI QR코드

DOI QR Code

The Guideline of Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder: Developed by ADHD Translational Research Center

주의력결핍 과잉행동장애 진단 및 치료: ADHD 중개연구센터 가이드라인

  • Lee, Sumin (Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University College of Medicine) ;
  • Choi, Jae-Won (Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University College of Medicine) ;
  • Kim, Kyoung-Min (Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University College of Medicine) ;
  • Kim, Jun Won (Department of Psychiatry, Catholic University of Daegu School of Medicine) ;
  • Kim, Sooyeon (Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University College of Medicine) ;
  • Kang, Taewoong (Inarae Psychiatric Clinic) ;
  • Kim, Johanna Inhyang (Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University College of Medicine) ;
  • Lee, Young Sik (Department of Psychiatry, Chung-Ang University Hospital, College of Medicine, Chung-Ang University) ;
  • Kim, Bongseog (Department of Psychiatry, Sanggye Paik Hospital, School of Medicine, Inje University) ;
  • Han, Doug Hyun (Department of Psychiatry, Chung-Ang University Hospital, College of Medicine, Chung-Ang University) ;
  • Cheong, Jae Hoon (Uimyung Research Institute for Neuroscience, Sahmyook University) ;
  • Lee, Soyoung Irene (Department of Psychiatry, Soonchunhyang University College of Medicine, Bucheon Hospital) ;
  • Hyun, Gi Jung (Department of Psychiatry, Chung-Ang University Hospital, College of Medicine, Chung-Ang University) ;
  • Kim, Bung-Nyun (Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University College of Medicine)
  • 이수민 (서울대학교 의과대학 정신건강의학교실 소아정신분과) ;
  • 최재원 (서울대학교 의과대학 정신건강의학교실 소아정신분과) ;
  • 김경민 (서울대학교 의과대학 정신건강의학교실 소아정신분과) ;
  • 김준원 (대구가톨릭대학교 의과대학 정신건강의학교실) ;
  • 김수연 (서울대학교 의과대학 정신건강의학교실 소아정신분과) ;
  • 강태웅 (아이나래 정신건강의학과의원) ;
  • 김인향 (서울대학교 의과대학 정신건강의학교실 소아정신분과) ;
  • 이영식 (중앙대학교 의과대학 중앙대학교병원 정신건강의학교실) ;
  • 김봉석 (인제대학교 의과대학 상계백병원 정신건강의학교실) ;
  • 한덕현 (중앙대학교 의과대학 중앙대학교병원 정신건강의학교실) ;
  • 정재훈 (삼육대학교 의명신경과학연구소) ;
  • 이소영 (순천향대학교 의과대학 부천병원 정신건강의학교실) ;
  • 현기정 (중앙대학교 의과대학 중앙대학교병원 정신건강의학교실) ;
  • 김붕년 (서울대학교 의과대학 정신건강의학교실 소아정신분과)
  • Received : 2016.11.07
  • Accepted : 2016.12.28
  • Published : 2016.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Attention-deficit hyperactivity disorder (ADHD) is one of the most common childhood psychiatric conditions. In 2007, the Korean Academy of child and Adolescent Psychiatry developed Korean ADHD practice parameter. Advances in the scientific evidence of ADHD caused practice parameter to be modified and updated. The present guidelines developed by ADHD translational research center summarize current literature for the treatment of ADHD in children and adults. This parameter includes the clinical evaluation for ADHD, comorbid conditions associated with ADHD, clinical feature and course, research on the etiology of the disorder, and psychopharmacological and non-pharmacological treatments for ADHD.

Keywords

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington, DC: American Psychiatric Assocition;2013.
  2. The Royal Australasian College of Physicians. Draft Australian Guidelines on Attention Deficit Hyperactivity Disorder (ADHD). St. Kilda: RACP;2009.
  3. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance. Canadian ADHD practice guidelines. 3th ed. Toronto, ON: CADDRA;2011.
  4. Cho SC, Kim BN, Kim JW, Kim HW, Choi HJ, Jung SW, et al. The reliability and validity of diagnostic interview schedule for children version IV-Korean version (DISC-IV). J Korean Acad Child Adolesc Psychiatry 2007;18:138-144.
  5. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, et al. The reliability and validity of kiddie-schedule for affective disorders and schizophrenia-present and lifetime version- Korean version (K-SADS-PL-K). Yonsei Med J 2004;45:81-89. https://doi.org/10.3349/ymj.2004.45.1.81
  6. Jang SJ, Suh DS, Byun HJ. Normative study of the K-ARS (Korean ADHD Rating Scale) for parents. J Korean Acad Child Adolesc Psychiatry 2007;18:38-48.
  7. Kim Y, Jung HY, Roh S. Rating Scales for Attention-Deficit Hyperactivity Disorder in Adults. J Korean Acad Child Adolesc Psychiatry 2010;21:11-16. https://doi.org/10.5765/jkacap.2010.21.1.011
  8. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-890. https://doi.org/10.1176/ajp.150.6.885
  9. Barkley RA, Murphy KR. Attention-deficit hyperactivity disorder: a clinical workbook. 2nd ed. New York: Guilford Press;1998.
  10. Chang MS. The validation of Conners' adult ADHD Scale-Korean (Shot version). Kor J Clin Psychol 2008;27:499-513.
  11. Kim EJ. The validation of Korean adult ADHD Scale (K-AADHDS). Kor J Clin Psychol 2003;22:897-911.
  12. Corkum PV, Siegel LS. Is the continuous performance task a valuable research tool for use with children with attention-deficit hyperactivity disorder? J Child Psychol Psychiatry 1993;34:1217-1239. https://doi.org/10.1111/j.1469-7610.1993.tb01784.x
  13. Seo JM, Lee JS, Kim SY, Kim HW. Diagnostic significance of comprehensive attention test in children and adolescents with attention- deficit hyperactivity disorder. J Korean Acad Child Adolesc Psychiatry 2011;22:246-252. https://doi.org/10.5765/jkacap.2011.22.4.246
  14. Thaler NS, Bello DT, Etcoff LM. WISC-IV profiles are associated with differences in symptomatology and outcome in children with ADHD. J Atten Disord 2013;17:291-301. https://doi.org/10.1177/1087054711428806
  15. Min JW, Lee WH, Hong MH, Bahn GH. A pilot study of the usefulness of intelligence test in assessment of attention-deficit hyperactivity disorder. J Korean Acad Child Adolesc Psychiatry 2012; 23:196-203. https://doi.org/10.5765/jkacap.2012.23.4.196
  16. Faraone SV, Khan SA. Candidate gene studies of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 2006;67 Suppl 8:13-20. https://doi.org/10.4088/JCP.1006e13
  17. Park S, Jeong HW, Kim BN, Cho SC, Kim JW, Shin MS, et al. Perinatal and developmental risk factors of ADHD children diagnosed with a structured interview. J Korean Acad Child Adolesc Psychiatry 2012;23:181-187. https://doi.org/10.5765/jkacap.2012.23.4.181
  18. Kim HW, Cho SC, Kim BN, Kim JW, Shin MS, Kim Y. Perinatal and familial risk factors are associated with full syndrome and subthreshold attention-deficit hyperactivity disorder in a Korean community sample. Psychiatry Investig 2009;6:278-285. https://doi.org/10.4306/pi.2009.6.4.278
  19. Hesdorffer DC, Ludvigsson P, Olafsson E, Gudmundsson G, Kjartansson O, Hauser WA. ADHD as a risk factor for incident unprovoked seizures and epilepsy in children. Arch Gen Psychiatry 2004;61:731-736. https://doi.org/10.1001/archpsyc.61.7.731
  20. Socanski D, Aurlien D, Herigstad A, Thomsen PH, Larsen TK. Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD). Seizure 2013;22:651-655. https://doi.org/10.1016/j.seizure.2013.04.021
  21. Caplan R, Siddarth P, Stahl L, Lanphier E, Vona P, Gurbani S, et al. Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities. Epilepsia 2008;49:1838-1846. https://doi.org/10.1111/j.1528-1167.2008.01680.x
  22. Snyder SM, Hall JR, Cornwell SL, Quintana H. Review of clinical validation of ADHD behavior rating scales. Psychol Rep 2006; 99:363-378. https://doi.org/10.2466/pr0.99.2.363-378
  23. Loo SK, Makeig S. Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update. Neurotherapeutics 2012;9: 569-587. https://doi.org/10.1007/s13311-012-0131-z
  24. Snyder SM, Quintana H, Sexson SB, Knott P, Haque AF, Reynolds DA. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res 2008; 159:346-358. https://doi.org/10.1016/j.psychres.2007.05.006
  25. Sadek J. A Clinician's Guide to ADHD. Cham: Springer;2014.
  26. Lahey BB, Pelham WE, Loney J, Kipp H, Ehrhardt A, Lee SS, et al. Three-year predictive validity of DSM-IV attention deficit hyperactivity disorder in children diagnosed at 4-6 years of age. Am J Psychiatry 2004;161:2014-2020. https://doi.org/10.1176/appi.ajp.161.11.2014
  27. Riddle MA, Yershova K, Lazzaretto D, Paykina N, Yenokyan G, Greenhill L, et al. The preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry 2013;52:264-278.e2. https://doi.org/10.1016/j.jaac.2012.12.007
  28. Egger HL, Kondo D, Angold A. The epidemiology and diagnostic issues in preschool attention-deficit/ hyperactivity disorder: a review. Infants and Young Children 2006;19:109-122. https://doi.org/10.1097/00001163-200604000-00004
  29. Polanczyk G, Jensen P. Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update. Child Adolesc Psychiatr Clin N Am 2008;17:245-260, vii. https://doi.org/10.1016/j.chc.2007.11.006
  30. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis.Am J Psychiatry. 2007;164:942-948. https://doi.org/10.1176/ajp.2007.164.6.942
  31. Safer DJ, Zito JM. Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder. In: Greenhill LL, Osman BB, editors. Ritalin: theory and practice. New York: Mary Ann Liebert;2000. p.7-26.
  32. Robison LM, Skaer TL, Sclar DA, Galin RS. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants. CNS Drugs 2002;16: 129-137. https://doi.org/10.2165/00023210-200216020-00005
  33. Brault MC, Lacourse E. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007. Can J Psychiatry 2012;57:93-101. https://doi.org/10.1177/070674371205700206
  34. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr 2012;12:78.
  35. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 2014; 43:434-442. https://doi.org/10.1093/ije/dyt261
  36. Kim JY, Ahn DH, Shin YJ. An epidemiological study of attentiondeficits hyperactivity disorder and learning disabilities in a rural area. J Korean Neuropsychiatr Assoc 1999;38:784-793.
  37. Cho SC, Shin YO. Prevalence of disruptive behavior disorders. J Korean Acad Child Adolesc Psychiatry 1994,5:141-149.
  38. Yang SJ, Cheong S, Hong SD. Prevalence and correlates of attention deficit hyperactivity disorder: school-based mental health services in Seoul. J Korean Neuropsychiatr Assoc 2006;45:69-76.
  39. Kim DW, Lee JE, Jung WC, Nam KC, Bang YW, Kim SJ, et al. Cross sectional study on the prevalence of attention deficit hyperactivity disorder and associated factors among elementary school students living nearby Shihwa-Banwol industrial complex. Korean J Occup Environ Med 2012;24:252-262.
  40. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012; 9:490-499. https://doi.org/10.1007/s13311-012-0135-8
  41. Faraone SV, Biederman J, Weber W, Russell RL. Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder: results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry 1998;37: 185-193. https://doi.org/10.1097/00004583-199802000-00011
  42. Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996;153:1143-1146. https://doi.org/10.1176/ajp.153.9.1143
  43. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: metaanalysis. Br J Psychiatry 2009;194:204-211. https://doi.org/10.1192/bjp.bp.107.048827
  44. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723. https://doi.org/10.1176/ajp.2006.163.4.716
  45. Park S, Cho MJ, Chang SM, Jeon HJ, Cho SJ, Kim BS, et al. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study. Psychiatry Res 2011;186:378-383. https://doi.org/10.1016/j.psychres.2010.07.047
  46. Kwak YS, Jung YE, Kim MD. Prevalence and correlates of attention- deficit hyperactivity disorder symptoms in Korean college students. Neuropsychiatr Dis Treat 2015;11:797-802.
  47. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, et al. Childhood predictors of adult attention-deficit/ hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry 2009;65: 46-54. https://doi.org/10.1016/j.biopsych.2008.10.005
  48. Kessler RC, Green JG, Adler LA, Barkley RA, Chatterji S, Faraone SV, et al. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry 2010; 67:1168-1178. https://doi.org/10.1001/archgenpsychiatry.2010.146
  49. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of followup studies. Psychol Med 2006;36:159-165.
  50. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000;157:816- 818. https://doi.org/10.1176/appi.ajp.157.5.816
  51. Barkley RA, Murphy KR, Dupaul GI, Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 2002;8:655-672.
  52. Robin L, Eleanor Payson. The impact of ADHD on marriage. [cited 2015 Nov 25]. Available from: http://www.adders.org/partners1.pdf.
  53. Mannuzza S, Klein RG, Moulton JL 3rd. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res 2008;160:237-246. https://doi.org/10.1016/j.psychres.2007.11.003
  54. Biederman J, Petty CR, Fried R, Kaiser R, Dolan CR, Schoenfeld S, et al. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry 2008;69:1217-1222. https://doi.org/10.4088/JCP.v69n0803
  55. de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, et al. The prevalence and effects of adult attention-deficit/ hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 2008;65:835-842. https://doi.org/10.1136/oem.2007.038448
  56. Akutagava-Martins GC, Salatino-Oliveira A, Kieling CC, Rohde LA, Hutz MH. Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. Expert Rev Neurother 2013;13:435-445. https://doi.org/10.1586/ern.13.30
  57. Anney RJ, Lasky-Su J, O'Dushlaine C, Kenny E, Neale BM, Mulligan A, et al. Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet B Neuropsychiatr Genet 2008;147B(8):1369-1378. https://doi.org/10.1002/ajmg.b.30871
  58. Biederman J, Faraone SV, Petty C, Martelon M, Woodworth KY, Wozniak J. Further evidence that pediatric-onset bipolar disorder comorbid with ADHD represents a distinct subtype: results from a large controlled family study. J Psychiatr Res 2013;47:15-22. https://doi.org/10.1016/j.jpsychires.2012.08.002
  59. Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 2010; 19:281-295. https://doi.org/10.1007/s00787-010-0092-x
  60. Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 2010;33:159-180. https://doi.org/10.1016/j.psc.2009.12.004
  61. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009;126:51-90. https://doi.org/10.1007/s00439-009-0694-x
  62. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1392-1398. https://doi.org/10.1002/ajmg.b.30878
  63. Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013;45:984-994. https://doi.org/10.1038/ng.2711
  64. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2010;49:884-897. https://doi.org/10.1016/j.jaac.2010.06.008
  65. Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Hum Genet 2009;126:13-50. https://doi.org/10.1007/s00439-009-0663-4
  66. Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007; 96:1269-1274. https://doi.org/10.1111/j.1651-2227.2007.00430.x
  67. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-289. https://doi.org/10.1037/0021-843X.111.2.279
  68. Galéra C, Côté SM, Bouvard MP, Pingault JB, Melchior M, Michel G, et al. Early risk factors for hyperactivity-impulsivity and inattention trajectories from age 17 months to 8 years. Arch Gen Psychiatry 2011;68:1267-1275. https://doi.org/10.1001/archgenpsychiatry.2011.138
  69. Pingault JB, Tremblay RE, Vitaro F, Carbonneau R, Genolini C, Falissard B, et al. Childhood trajectories of inattention and hyperactivity and prediction of educational attainment in early adulthood: a 16-year longitudinal population-based study. Am J Psychiatry 2011;168:1164-1170. https://doi.org/10.1176/appi.ajp.2011.10121732
  70. Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921. https://doi.org/10.1097/chi.0b013e318054e724
  71. Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 2009;29:656-679. https://doi.org/10.1592/phco.29.6.656
  72. Nagin D, Tremblay RE. Trajectories of boys' physical aggression, opposition, and hyperactivity on the path to physically violent and nonviolent juvenile delinquency. Child Dev 1999;70:1181-1196. https://doi.org/10.1111/1467-8624.00086
  73. Larsson H, Dilshad R, Lichtenstein P, Barker ED. Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. J Child Psychol Psychiatry 2011;52:954-963. https://doi.org/10.1111/j.1469-7610.2011.02379.x
  74. Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 2005;28:397-419; discussion 419-468.
  75. García-Castellar R, Presentación-Herrero MJ, Siegenthaler-Hierro R, Miranda-Casas A. [The sociometric status of children with the combined subtype of attention deficit hyperactivity disorder]. Rev Neurol 2006;42 Suppl 2:S13-S17.
  76. Eiraldi RB, Power TJ, Nezu CM. Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children. J Am Acad Child Adolesc Psychiatry 1997;36:503-514. https://doi.org/10.1097/00004583-199704000-00013
  77. Tzang RF, Chang YC, Liu SI. The association between children's ADHD subtype and parenting stress and parental symptoms. Int J Psychiatry Clin Pract 2009;13:318-325. https://doi.org/10.3109/13651500903094567
  78. Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, et al. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol 2012;121:991-1010. https://doi.org/10.1037/a0027347
  79. Kindlon D, Mezzacappa E, Earls F. Psychometric properties of impulsivity measures: temporal stability, validity and factor structure. J Child Psychol Psychiatry 1995;36:645-661. https://doi.org/10.1111/j.1469-7610.1995.tb02319.x
  80. Babinski LM, Hartsough CS, Lambert NM. Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity. J Child Psychol Psychiatry 1999;40:347- 355. https://doi.org/10.1111/1469-7610.00452
  81. Polderman TJ, Boomsma DI, Bartels M, Verhulst FC, Huizink AC. A systematic review of prospective studies on attention problems and academic achievement. Acta Psychiatr Scand 2010;122:271- 284. https://doi.org/10.1111/j.1600-0447.2010.01568.x
  82. Maedgen JW, Carlson CL. Social functioning and emotional regulation in the attention deficit hyperactivity disorder subtypes. J Clin Child Psychol 2000;29:30-42. https://doi.org/10.1207/S15374424jccp2901_4
  83. Boonstra AM, Oosterlaan J, Sergeant JA, Buitelaar JK. Executive functioning in adult ADHD: a meta-analytic review. Psychol Med 2005;35:1097-1108. https://doi.org/10.1017/S003329170500499X
  84. Welsh MC, Pennington BF. Assessing frontal lobe functioning in children: views from developmental psychology. Dev Neuropsychol 1988;4:199-230. https://doi.org/10.1080/87565648809540405
  85. Diamond A. Executive functions. Annu Rev Psychol 2013;64:135- 168. https://doi.org/10.1146/annurev-psych-113011-143750
  86. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 2005;57: 1336-1346. https://doi.org/10.1016/j.biopsych.2005.02.006
  87. Kasper LJ, Alderson RM, Hudec KL. Moderators of working memory deficits in children with attention-deficit/hyperactivity disorder (ADHD): a meta-analytic review. Clin Psychol Rev 2012; 32:605-617. https://doi.org/10.1016/j.cpr.2012.07.001
  88. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121:65-94. https://doi.org/10.1037/0033-2909.121.1.65
  89. Rapport MD, Chung KM, Shore G, Isaacs P. A conceptual model of child psychopathology: implications for understanding attention deficit hyperactivity disorder and treatment efficacy. J Clin Child Psychol 2001;30:48-58. https://doi.org/10.1207/S15374424JCCP3001_6
  90. Baddeley A. Working memory, thought, and action. New York: Oxford University Press;2007.
  91. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A metaanalysis of working memory impairments in children with attention- deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2005;44:377-384. https://doi.org/10.1097/01.chi.0000153228.72591.73
  92. Haenlein M, Caul WF. Attention deficit disorder with hyperactivity: a specific hypothesis of reward dysfunction. J Am Acad Child Adolesc Psychiatry 1987;26:356-362. https://doi.org/10.1097/00004583-198705000-00014
  93. Luman M, Oosterlaan J, Sergeant JA. The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. Clin Psychol Rev 2005;25:183-213. https://doi.org/10.1016/j.cpr.2004.11.001
  94. Hoerger ML, Mace FC. A computerized test of self-control predicts classroom behavior. J Appl Behav Anal 2006;39:147-159. https://doi.org/10.1901/jaba.2006.171-04
  95. Antrop I, Stock P, Verté S, Wiersema JR, Baeyens D, Roeyers H. ADHD and delay aversion: the influence of non-temporal stimulation on choice for delayed rewards. J Child Psychol Psychiatry 2006;47:1152-1158. https://doi.org/10.1111/j.1469-7610.2006.01619.x
  96. Sonuga-Barke EJ, Sergeant JA, Nigg J, Willcutt E. Executive dysfunction and delay aversion in attention deficit hyperactivity disorder: nosologic and diagnostic implications. Child Adolesc Psychiatr Clin N Am 2008;17:367-384, ix. https://doi.org/10.1016/j.chc.2007.11.008
  97. Klotz JM, Johnson MD, Wu SW, Isaacs KM, Gilbert DL. Relationship between reaction time variability and motor skill development in ADHD. Child Neuropsychol 2012;18:576-585. https://doi.org/10.1080/09297049.2011.625356
  98. Adams ZW, Roberts WM, Milich R, Fillmore MT. Does response variability predict distractibility among adults with attention-deficit/ hyperactivity disorder? Psychol Assess 2011;23:427-436. https://doi.org/10.1037/a0022112
  99. Verte S, Geurts HM, Roeyers H, Oosterlaan J, Sergeant JA. Executive functioning in children with autism and Tourette syndrome. Dev Psychopathol 2005;17:415-445.
  100. Kaiser S, Roth A, Rentrop M, Friederich HC, Bender S, Weisbrod M. Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder. Brain Cogn 2008; 66:73-82. https://doi.org/10.1016/j.bandc.2007.05.007
  101. Bora E, Vahip S, Akdeniz F. Sustained attention deficits in manic and euthymic patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1097-1102. https://doi.org/10.1016/j.pnpbp.2006.04.016
  102. Segalowitz SJ, Dywan J, Unsal A. Attentional factors in response time variability after traumatic brain injury: an ERP study. J Int Neuropsychol Soc 1997;3:95-107.
  103. Kofler MJ, Rapport MD, Sarver DE, Raiker JS, Orban SA, Friedman LM, et al. Reaction time variability in ADHD: a meta-analytic review of 319 studies. Clin Psychol Rev 2013;33:795-811. https://doi.org/10.1016/j.cpr.2013.06.001
  104. Martel MM. Research review: a new perspective on attention-deficit/ hyperactivity disorder: emotion dysregulation and trait models. J Child Psychol Psychiatry 2009;50:1042-1051. https://doi.org/10.1111/j.1469-7610.2009.02105.x
  105. Yuill N, Lyon J. Selective difficulty in recognising facial expressions of emotion in boys with ADHD. General performance impairments or specific problems in social cognition? Eur Child Adolesc Psychiatry 2007;16:398-404. https://doi.org/10.1007/s00787-007-0612-5
  106. Walcott CM, Landau S. The relation between disinhibition and emotion regulation in boys with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol 2004;33:772-782. https://doi.org/10.1207/s15374424jccp3304_12
  107. Barkley RA. ADHD and the Nature of Self-control. New York: The Guilford Press;1997.
  108. Berlin L, Bohlin G, Nyberg L, Janols LO. How well do measures of inhibition and other executive functions discriminate between children with ADHD and controls? Child Neuropsychol 2004;10: 1-13. https://doi.org/10.1076/chin.10.1.1.26243
  109. Blaskey LG, Harris LJ, Nigg JT. Are sensation seeking and emotion processing related to or distinct from cognitive control in children with ADHD? Child Neuropsychol 2008;14:353-371. https://doi.org/10.1080/09297040701660291
  110. Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. New York: Guilford Publications;2014.
  111. Toplak ME, Dockstader C, Tannock R. Temporal information processing in ADHD: findings to date and new methods. J Neurosci Methods 2006;151:15-29. https://doi.org/10.1016/j.jneumeth.2005.09.018
  112. Bergstrom K, Bille B. Computed tomography of the brain in children with minimal brain damage: a preliminary study of 46 children. Neuropadiatrie 1978;9:378-384. https://doi.org/10.1055/s-0028-1091497
  113. Thompson JS, Ross RJ, Horwitz SJ. The role of computed axial tomography in the study of the child with minimal brain dysfunction. J Learn Disabil 1980;13:334-337.
  114. Pontius AA. Dysfunction patterns analogous to frontal lobe system and caudate nucleus syndromes in some groups of minimal brain dysfunction. J Am Med Womens Assoc 1973;26:285-292.
  115. Giedd JN, Blumenthal J, Molloy E, Castellanos FX. Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci 2001; 931:33-49.
  116. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50: 565-576. https://doi.org/10.1001/archpsyc.1993.01820190067007
  117. Greydanus DE, Pratt HD, Patel DR. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult. Dis Mon 2007;53:70-131. https://doi.org/10.1016/j.disamonth.2007.01.001
  118. Conners CK, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales (CAARS). Toronto: MHS;1999.
  119. Brown TE. Brown Attention-Deficit Disorder $Scales{(R)}$ (Brown- ADD Scales). San Antonio, TX: The Psychological Corporation; 1996.
  120. McCann BS, Scheele L, Ward N, Roy-Byrne P. Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. J Neuropsychiatry Clin Neurosci 2000;12: 240-245. https://doi.org/10.1176/jnp.12.2.240
  121. Schmitt J, Romanos M, Schmitt NM, Meurer M, Kirch W. Atopic eczema and attention-deficit/hyperactivity disorder in a population- based sample of children and adolescents. JAMA 2009;301: 724-726. https://doi.org/10.1001/jama.2009.136
  122. Reyero F, Ponce G, Rodriguez-Jimenez R, Fernandez-Dapica P, Taboada D, Martin V, et al. High frequency of childhood ADHD history in women with fibromyalgia. Eur Psychiatry 2011;26:482- 483.
  123. Cortese S, Faraone SV, Konofal E, Lecendreux M. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry 2009;48:894-908.
  124. Pelsser LM, Buitelaar JK, Savelkoul HF. ADHD as a (non) allergic hypersensitivity disorder: a hypothesis. Pediatr Allergy Immunol 2009;20:107-112. https://doi.org/10.1111/j.1399-3038.2008.00749.x
  125. Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME. Migraine, tension-type headache, and attention-deficit/hyperactivity disorder in childhood: a population-based study. Postgrad Med 2010;122:18-26. https://doi.org/10.3810/pgm.2010.09.2197
  126. Shaw P, Lerch J, Greenstein D, Sharp W, Clasen L, Evans A, et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006;63:540-549. https://doi.org/10.1001/archpsyc.63.5.540
  127. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005;35:245-256. https://doi.org/10.1017/S0033291704002892
  128. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 1994;53:13-29. https://doi.org/10.1016/0165-1781(94)90092-2
  129. Barkley RA, Murphy KR. Attention-deficit hyperactivity disorder: a clinical workbook. New York: Guilford Press;1998.
  130. Solanto MV, Marks DJ, Mitchell KJ, Wasserstein J, Kofman MD. Development of a new psychosocial treatment for adult ADHD. J Atten Disord 2008;11:728-736. https://doi.org/10.1177/1087054707305100
  131. Tian L, Jiang T, Liang M, Zang Y, He Y, Sui M, et al. Enhanced resting-state brain activities in ADHD patients: a fMRI study. Brain Dev 2008;30:342-348. https://doi.org/10.1016/j.braindev.2007.10.005
  132. Castellanos FX, Margulies DS, Kelly C, Uddin LQ, Ghaffari M, Kirsch A, et al. Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2008;63:332-337. https://doi.org/10.1016/j.biopsych.2007.06.025
  133. Rubia K, Cubillo A, Smith AB, Woolley J, Heyman I, Brammer MJ. Disorder-specific dysfunction in right inferior prefrontal cortex during two inhibition tasks in boys with attention-deficit hyperactivity disorder compared to boys with obsessive-compulsive disorder. Hum Brain Mapp 2010;31:287-299.
  134. Elkins IJ, McGue M, Iacono WG. Prospective effects of attentiondeficit/ hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007;64: 1145-1152. https://doi.org/10.1001/archpsyc.64.10.1145
  135. O'Brien LM, Gozal D. Sleep in children with attention deficit/hyperactivity disorder. Minerva Pediatr 2004;56:585-601.
  136. Konrad A, Dielentheis TF, El Masri D, Bayerl M, Fehr C, Gesierich T, et al. Disturbed structural connectivity is related to inattention and impulsivity in adult attention deficit hyperactivity disorder. Eur J Neurosci 2010;31:912-919. https://doi.org/10.1111/j.1460-9568.2010.07110.x
  137. Ashtari M, Kumra S, Bhaskar SL, Clarke T, Thaden E, Cervellione KL, et al. Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol Psychiatry 2005;57:448-455. https://doi.org/10.1016/j.biopsych.2004.11.047
  138. Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 2012;69:1295-1303. https://doi.org/10.1001/archgenpsychiatry.2012.271
  139. Cortese S, Angriman M, Maffeis C, Isnard P, Konofal E, Lecendreux M, et al. Attention-deficit/hyperactivity disorder (ADHD) and obesity: a systematic review of the literature. Crit Rev Food Sci Nutr 2008;48:524-537. https://doi.org/10.1080/10408390701540124
  140. Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord 2002;5:189-202.
  141. Larson K, Russ SA, Kahn RS, Halfon N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 2011;127:462-470. https://doi.org/10.1542/peds.2010-0165
  142. McCann BS, Roy-Byrne P. Screening and diagnostic utility of selfreport attention deficit hyperactivity disorder scales in adults. Compr Psychiatry 2004;45:175-183. https://doi.org/10.1016/j.comppsych.2004.02.006
  143. Adler L, Cohen J. Diagnosis and evaluation of adults with attention- deficit/hyperactivity disorder. Psychiatr Clin North Am 2004; 27:187-201. https://doi.org/10.1016/j.psc.2003.12.003
  144. Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M, et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? evidence from a four-decade longitudinal cohort study. Am J Psychiatry 2015;172:967-977. https://doi.org/10.1176/appi.ajp.2015.14101266
  145. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 1996;37:393-401. https://doi.org/10.1016/S0010-440X(96)90022-X
  146. Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A, et al. Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention- Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 2007;17:547-562. https://doi.org/10.1089/cap.2007.0075
  147. Vitiello B, Lazzaretto D, Yershova K, Abikoff H, Paykina N, Mc- Cracken JT, et al. Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up. J Am Acad Child Adolesc Psychiatry 2015;54:550-556. https://doi.org/10.1016/j.jaac.2015.04.004
  148. Souza I, Pinheiro MA, Mattos P. [Anxiety disorders in an attention- deficit/hyperactivity disorder clinical sample]. Arq Neuropsiquiatr 2005;63:407-409. https://doi.org/10.1590/S0004-282X2005000300008
  149. Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. J Pediatr Psychol 2007;32:643-654. https://doi.org/10.1093/jpepsy/jsl054
  150. Bizzarri JV, Rucci P, Sbrana A, Gonnelli C, Massei GJ, Ravani L, et al. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders. Addict Behav 2007;32:384-391. https://doi.org/10.1016/j.addbeh.2006.04.005
  151. Yoshimasu K, Barbaresi WJ, Colligan RC, Voigt RG, Killian JM, Weaver AL, et al. Childhood ADHD is strongly associated with a broad range of psychiatric disorders during adolescence: a population- based birth cohort study. J Child Psychol Psychiatry 2012;53: 1036-1043. https://doi.org/10.1111/j.1469-7610.2012.02567.x
  152. Sachs GS, Baldassano CF, Truman CJ, Guille C. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry 2000;157:466-468. https://doi.org/10.1176/appi.ajp.157.3.466
  153. Ko CH, Yen JY, Yen CF, Chen CS, Chen CC. The association between Internet addiction and psychiatric disorder: a review of the literature. Eur Psychiatry 2012;27:1-8.
  154. Ha JH, Yoo HJ, Cho IH, Chin B, Shin D, Kim JH. Psychiatric comorbidity assessed in Korean children and adolescents who screen positive for Internet addiction. J Clin Psychiatry 2006;67:821- 826. https://doi.org/10.4088/JCP.v67n0517
  155. Kent KM, Pelham WE Jr, Molina BS, Sibley MH, Waschbusch DA, Yu J, et al. The academic experience of male high school students with ADHD. J Abnorm Child Psychol 2011;39:451-462. https://doi.org/10.1007/s10802-010-9472-4
  156. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000;157: 816-818. https://doi.org/10.1176/appi.ajp.157.5.816
  157. Nigg JT, Stavro G, Ettenhofer M, Hambrick DZ, Miller T, Henderson JM. Executive functions and ADHD in adults: evidence for selective effects on ADHD symptom domains. J Abnorm Psychol 2005;114:706-717. https://doi.org/10.1037/0021-843X.114.3.706
  158. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005;57:1215-1220. https://doi.org/10.1016/j.biopsych.2004.10.020
  159. Dopfner M, Breuer D, Wille N, Erhart M, Ravens-Sieberer U; BELLA study group. How often do children meet ICD-10/DSMIV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample-- results of the BELLA study. Eur Child Adolesc Psychiatry 2008;17 Suppl 1:59-70. https://doi.org/10.1007/s00787-008-1007-y
  160. Kim HY, Lee JY, Cho SS, Lee IS, Kim JH. A preliminary study on reliability and validity of the conners adult ADHD Rating Scales- Korean version in college students. Korean J Clin Psychol 2005;24: 171-185.
  161. Connor DF, Steeber J, McBurnett K. A review of attention-deficit/ hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr 2010;31: 427-440. https://doi.org/10.1097/DBP.0b013e3181e121bd
  162. Millstein RB, Wilens TE, Biederman J, Spencer TJ. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Atten Disord 1997;2:159-166. https://doi.org/10.1177/108705479700200302
  163. Derogatis LR. SCL-90. Administration, scoring and procedures manual-I for the R (revised) version and other instruments of the Psychopathology Rating Scales Series. Chicago: Johns Hopkins University School of Medicine, 1977.
  164. Jain M, Palacio LG, Castellanos FX, Palacio JD, Pineda D, Restrepo MI, et al. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci. Biol Psychiatry 2007;61:1329-1339. https://doi.org/10.1016/j.biopsych.2006.06.026
  165. Christiansen H, Chen W, Oades RD, Asherson P, Taylor EA, Lasky-Su J, et al. Co-transmission of conduct problems with attention- deficit/hyperactivity disorder: familial evidence for a distinct disorder. J Neural Transm (Vienna) 2008;115:163-175. https://doi.org/10.1007/s00702-007-0837-y
  166. Lee WI, Kim JJ. A Preliminary Study on the Relationship between Drug Reactions Effects, Personality Type and ADHD Subtypes in Adult ADHD. Chung-Ang J Med 2012;37:59-64.
  167. Loeber R, Green SM, Lahey BB, Frick PJ, McBurnett K. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev 2000;3: 37-60. https://doi.org/10.1023/A:1009567419190
  168. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995;152:1652-1658. https://doi.org/10.1176/ajp.152.11.1652
  169. Ostrander R, Crystal DS, August G. Attention deficit-hyperactivity disorder, depression, and self- and other-assessments of social competence: a developmental study. J Abnorm Child Psychol 2006;34:773-787.
  170. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schwartz J. Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder. J Clin Psychopharmacol 2002;22:267-274. https://doi.org/10.1097/00004714-200206000-00007
  171. Kunwar A, Dewan M, Faraone SV. Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 2007;8:555-562. https://doi.org/10.1517/14656566.8.5.555
  172. Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, et al. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry 2005;58:125-131. https://doi.org/10.1016/j.biopsych.2005.04.040
  173. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011;31:328-341. https://doi.org/10.1016/j.cpr.2011.01.006
  174. Donfrancesco R, Miano S, Martines F, Ferrante L, Melegari MG, Masi G. Bipolar disorder co-morbidity in children with attention deficit hyperactivity disorder. Psychiatry Res 2011;186:333-337. https://doi.org/10.1016/j.psychres.2010.07.008
  175. Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, et al. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry 2005;57:1467-1473. https://doi.org/10.1016/j.biopsych.2005.01.036
  176. Walshaw PD, Alloy LB, Sabb FW. Executive function in pediatric bipolar disorder and attention-deficit hyperactivity disorder: in search of distinct phenotypic profiles. Neuropsychol Rev 2010;20: 103-120. https://doi.org/10.1007/s11065-009-9126-x
  177. Murphy KR, Adler LA. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry 2004;65 Suppl 3:12-17.
  178. Rösler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006;256 Suppl 1:i3-i11. https://doi.org/10.1007/s00406-006-1001-7
  179. Biederman J, Ball SW, Monuteaux MC, Mick E, Spencer TJ, Mc- Creary M, et al. J Am Acad Child Adolesc Psychiatry 2008;47:426- 434. https://doi.org/10.1097/CHI.0b013e31816429d3
  180. Freitag CM, Rohde LA, Lempp T, Romanos M. Phenotypic and measurement influences on heritability estimates in childhood ADHD. Eur Child Adolesc Psychiatry 2010;19:311-323. https://doi.org/10.1007/s00787-010-0097-5
  181. Bowen R, Chavira DA, Bailey K, Stein MT, Stein MB. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting. Psychiatry Res 2008;157:201-209. https://doi.org/10.1016/j.psychres.2004.12.015
  182. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow- up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 2004;45:195-211. https://doi.org/10.1111/j.1469-7610.2004.00214.x
  183. Serra-Pinheiro MA, Coutinho ES, Souza IS, Pinna C, Fortes D, Araujo C, et al. Is ADHD a risk factor independent of conduct disorder for illicit substance use? A meta-analysis and metaregression investigation. J Atten Disord 2013;17:459-469. https://doi.org/10.1177/1087054711435362
  184. Spencer T, Biederman M, Coffey B, Geller D, Wilens T, Faraone S. The 4-year course of tic disorders in boys with attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry 1999;56:842-847. https://doi.org/10.1001/archpsyc.56.9.842
  185. Spencer TJ, Biederman J, Faraone S, Mick E, Coffey B, Geller D, et al. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD. Am J Psychiatry 2001;158:611-617. https://doi.org/10.1176/appi.ajp.158.4.611
  186. Himle MB, Woods DW. An experimental evaluation of tic suppression and the tic rebound effect. Behav Res Ther 2005;43:1443- 1451. https://doi.org/10.1016/j.brat.2004.11.002
  187. Kollins SH. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord 2008;12:115-125. https://doi.org/10.1177/1087054707311654
  188. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 2008;165:597-603. https://doi.org/10.1176/appi.ajp.2007.07091486
  189. Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 2003;112:497-507. https://doi.org/10.1037/0021-843X.112.3.497
  190. Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, et al. Does ADHD predict substance-use disorders? A 10-year follow- up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 2011;50:543-553. https://doi.org/10.1016/j.jaac.2011.01.021
  191. Kuczenski R, Segal DS. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 2005;57:1391-1396. https://doi.org/10.1016/j.biopsych.2004.12.036
  192. Groman SM, James AS, Jentsch JD. Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder. Neurosci Biobehav Rev 2009;33:690-698. https://doi.org/10.1016/j.neubiorev.2008.08.008
  193. Frodl T. Comorbidity of ADHD and substance use disorder (SUD): a neuroimaging perspective. J Atten Disord 2010;14:109-120. https://doi.org/10.1177/1087054710365054
  194. Yoo HJ, Cho SC, Ha J, Yune SK, Kim SJ, Hwang J, et al. Attention deficit hyperactivity symptoms and internet addiction. Psychiatry Clin Neurosci 2004;58:487-494. https://doi.org/10.1111/j.1440-1819.2004.01290.x
  195. Ko CH, Yen JY, Chen CS, Chen CC, Yen CF. Psychiatric comorbidity of internet addiction in college students: an interview study. CNS Spectr 2008;13:147-153. https://doi.org/10.1017/S1092852900016308
  196. Miller CJ, Flory JD, Miller SR, Harty SC, Newcorn JH, Halperin JM. Childhood attention-deficit/hyperactivity disorder and the emergence of personality disorders in adolescence: a prospective follow-up study. J Clin Psychiatry 2008;69:1477-1484. https://doi.org/10.4088/JCP.v69n0916
  197. Fossati A, Novella L, Donati D, Donini M, Maffei C. History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry 2002;43:369-377. https://doi.org/10.1053/comp.2002.34634
  198. Lampe K, Konrad K, Kroener S, Fast K, Kunert HJ, Herpertz SC. Neuropsychological and behavioural disinhibition in adult ADHD compared to borderline personality disorder. Psychol Med 2007; 37:1717-1729.
  199. Levy LD, Fleming JP, Klar D. Treatment of refractory obesity in severely obese adults following management of newly diagnosed attention deficit hyperactivity disorder. Int J Obes (Lond) 2009;33: 326-334. https://doi.org/10.1038/ijo.2009.5
  200. Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009;48:484-500. https://doi.org/10.1097/CHI.0b013e31819c23d0
  201. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attentiondeficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006;45:642-657. https://doi.org/10.1097/01.chi.0000215326.51175.eb
  202. Zuvekas SH, Vitiello B. Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 2012;169:160-166. https://doi.org/10.1176/appi.ajp.2011.11030387
  203. Southammakosane C, Schmitz K. Pediatric psychopharmacology for treatment of ADHD, depression, and anxiety. Pediatrics 2015; 136:351-359. https://doi.org/10.1542/peds.2014-1581
  204. Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:1007-1022. https://doi.org/10.1542/peds.2011-2654
  205. Yoo HJ, Yang SJ, Shin D, Kang H, Kim BN, Kim JH, et al. The Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (III) : Pharmacologic Treatment. J Korean Acad Child Adolesc Psychiatry 2007;18:16-25.
  206. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006;59:829-835. https://doi.org/10.1016/j.biopsych.2005.09.011
  207. Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001;40:147-158. https://doi.org/10.1097/00004583-200102000-00009
  208. Pelham WE Jr, Sturges J, Hoza J, Schmidt C, Bijlsma JJ, Milich R, et al. Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder. Pediatrics 1987;80:491-501.
  209. Armstrong RB, Damaraju CV, Ascher S, Schwarzman L, O'Neill J, Starr HL. Time course of treatment effect of $OROS^{(R)}$ methylphenidate in children with ADHD. J Atten Disord 2012;16:697-705. https://doi.org/10.1177/1087054711425772
  210. Wigal SB, Gupta S, Heverin E, Starr HL. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2011;21:255-263. https://doi.org/10.1089/cap.2010.0083
  211. Childress A, Sallee FR. The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD. Expert Rev Neurother 2013;13:979-988. https://doi.org/10.1586/14737175.2013.833002
  212. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, et al. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proofof- concept and proof-of-product studies. Arch Gen Psychiatry 2003;60:204-211. https://doi.org/10.1001/archpsyc.60.2.204
  213. Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol 2006;13:e50-e62.
  214. Anderson VR, Keating GM. Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder. Paediatr Drugs 2006;8:319-333. https://doi.org/10.2165/00148581-200608050-00005
  215. Brams M, Mao AR, Doyle RL. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgrad Med 2008;120:69-88. https://doi.org/10.3810/pgm.2008.09.1909
  216. Biederman J, Quinn D, Weiss M, Markabi S, Weidenman M, Edson K, et al. Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs 2003; 5:833-841. https://doi.org/10.2165/00148581-200305120-00006
  217. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 2006;45:1304-1313. https://doi.org/10.1097/01.chi.0000235075.25038.5a
  218. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45:1284-1293. https://doi.org/10.1097/01.chi.0000235077.32661.61
  219. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002;41(2 Suppl):26S-49S. https://doi.org/10.1097/00004583-200202001-00003
  220. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:21-31. https://doi.org/10.1097/chi.0b013e31815a56f1
  221. Kratochvil CJ, Vaughan BS, Harrington MJ, Burke WJ. Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 2003;4:1165-1174. https://doi.org/10.1517/14656566.4.7.1165
  222. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 2002;159:1896-1901. https://doi.org/10.1176/appi.ajp.159.11.1896
  223. Kratochvil CJ, Milton DR, Vaughan BS, Greenhill LL. Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy. Child Adolesc Psychiatry Ment Health 2008;2:25. https://doi.org/10.1186/1753-2000-2-25
  224. Tauscher-Wisniewski S, Nilsson M, Caldwell C, Plewes J, Allen AJ. Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo. J Child Adolesc Psychopharmacol 2007;17:713-718. https://doi.org/10.1089/cap.2006.0138
  225. Signorovitch J, Erder MH, Xie J, Sikirica V, Lu M, Hodgkins PS, et al. Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attentiondeficit/ hyperactivity disorder and comorbid oppositional defiant disorder. Pharmacoepidemiol Drug Saf 2012;21 Suppl 2:130-137.
  226. Sumner C, Sher L, Sutton V, Bakken R, Paczkowski M, Trzepacz P, et al. Atomoxetine treatment for pediatric patients with ADHD and comorbid anxiety. Neuropediatrics 2006;37:TP74.
  227. Schwartz S, Correll CU. Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. J Am Acad Child Adolesc Psychiatry 2014;53:174-187. https://doi.org/10.1016/j.jaac.2013.11.005
  228. Waxmonsky JG, Waschbusch DA, Akinnusi O, Pelham WE. A comparison of atomoxetine administered as once versus twice daily dosing on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2011;21:21-32. https://doi.org/10.1089/cap.2010.0042
  229. Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry 2002;63 Suppl 12:50-55.
  230. van Zwieten PA, Chalmers JP. Different types of centrally acting antihypertensives and their targets in the central nervous system. Cardiovasc Drugs Ther 1994;8:787-799. https://doi.org/10.1007/BF00877397
  231. Hunt RD, Arnsten AF, Asbell MD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:50-54. https://doi.org/10.1097/00004583-199501000-00013
  232. Posey DJ, McDougle CJ. Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. CNS Drug Rev 2007;13:465-474. https://doi.org/10.1111/j.1527-3458.2007.00026.x
  233. Hunt RD, Capper L, O'Connell P. Clonidine in child and adolescent psychiatry. J Child Adolesc Psychopharmacol 1990;1:87-102. https://doi.org/10.1089/cap.1990.1.87
  234. Hirota T, Schwartz S, Correll CU. Alpha-2 agonists for attentiondeficit/ hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. J Am Acad Child Adolesc Psychiatry 2014;53:153-173. https://doi.org/10.1016/j.jaac.2013.11.009
  235. Kollins SH, Jain R, Brams M, Segal S, Findling RL, Wigal SB, et al. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics 2011;127:e1406-e1413. https://doi.org/10.1542/peds.2010-1260
  236. Jain R, Segal S, Kollins SH, Khayrallah M. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2011;50:171-179. https://doi.org/10.1016/j.jaac.2010.11.005
  237. Croxtall JD. Clonidine extended-release in attention-deficit hyperactivity disorder: profile report. CNS Drugs 2012;26:277-279. https://doi.org/10.2165/11208310-000000000-00000
  238. Sallee F, Connor DF, Newcorn JH. A review of the rationale and clinical utilization of ${\alpha}2$-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders. J Child Adolesc Psychopharmacol 2013;23:308-319. https://doi.org/10.1089/cap.2013.0028
  239. Wang M, Ramos BP, Paspalas CD, Shu Y, Simen A, Duque A, et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 2007;129:397-410. https://doi.org/10.1016/j.cell.2007.03.015
  240. Newcorn JH, Schulz K, Harrison M, DeBellis MD, Udarbe JK, Halperin JM. Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. Pediatr Clin North Am 1998;45:1099-1022, viii. https://doi.org/10.1016/S0031-3955(05)70064-X
  241. Ruggiero S, Clavenna A, Reale L, Capuano A, Rossi F, Bonati M. Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis. Eur Neuropsychopharmacol 2014;24:1578-1590. https://doi.org/10.1016/j.euroneuro.2014.08.001
  242. Shier AC, Reichenbacher T, Ghuman HS, Ghuman JK. Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies. J Cent Nerv Syst Dis 2013;5:1-17.
  243. Daviss WB, Perel JM, Rudolph GR, Axelson DA, Gilchrist R, Nuss S, et al. Steady-state pharmacokinetics of bupropion SR in juvenile patients. J Am Acad Child Adolesc Psychiatry 2005;44: 349-357. https://doi.org/10.1097/01.chi.0000153225.26850.26
  244. Daviss WB, Perel JM, Birmaher B, Rudolph GR, Melhem I, Axelson DA, et al. Steady-state clinical pharmacokinetics of bupropion extended-release in youths. J Am Acad Child Adolesc Psychiatry 2006;45:1503-1509. https://doi.org/10.1097/01.chi.0000237704.05143.bd
  245. Dhillon S, Yang LP, Curran MP. Bupropion: a review of its use in the management of major depressive disorder. Drugs 2008;68:653-689. https://doi.org/10.2165/00003495-200868050-00011
  246. Meszaros A, Czobor P, Balint S, Komlosi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. Int J Neuropsychopharmacol 2009;12: 1137-1147. https://doi.org/10.1017/S1461145709990198
  247. Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficithyperactivity disorder. N Engl J Med 1999;340:780-788. https://doi.org/10.1056/NEJM199903113401007
  248. Waxmonsky JG. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults. Essent Psychopharmacol 2005;6:262-276.
  249. Taketomo CK, Hodding JH, Kraus DM. Lexi-Comp's Pediatric Dosage Handbook: Including Neonatal Dosing, Drug Administration, & Extemporaneous Preparations. Hudson, OH: Lexi-Comp; 2004.
  250. Stein BD, Klein GR, Greenhouse JB, Kogan JN. Treatment of attention- deficit hyperactivity disorder: patterns of evolving care during the first treatment episode. Psychiatr Serv 2012;63:122-129. https://doi.org/10.1176/appi.ps.201000532
  251. Emilsson B, Gudjonsson G, Sigurdsson JF, Baldursson G, Einarsson E, Olafsdottir H, et al. Cognitive behaviour therapy in medication- treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry 2011;11:116. https://doi.org/10.1186/1471-244X-11-116
  252. Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010;304:875-880. https://doi.org/10.1001/jama.2010.1192
  253. National Collaborating Centre for Mental Health (UK). Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. Leicester: British Psychological Society (UK);2009.
  254. Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ, et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 2010;10:67. https://doi.org/10.1186/1471-244X-10-67
  255. Gjervan B, Torgersen T, Nordahl HM, Rasmussen K. Functional impairment and occupational outcome in adults with ADHD. J Atten Disord 2012;16:544-552. https://doi.org/10.1177/1087054711413074
  256. Patterson GR. Coercive family process. Eugene, OR: Castalia Pub. Co.;1982.
  257. Hautmann C, Stein P, Hanisch C, Eichelberger I, Plück J, Walter D, et al. Does parent management training for children with externalizing problem behavior in routine care result in clinically significant changes? Psychother Res 2009;19:224-233. https://doi.org/10.1080/10503300902777148
  258. Sonuga-Barke EJ, Daley D, Thompson M, Laver-Bradbury C, Weeks A. Parent-based therapies for preschool attention-deficit/ hyperactivity disorder: a randomized, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry 2001;40:402-408. https://doi.org/10.1097/00004583-200104000-00008
  259. Barkley RA, Guevremont DC, Anastopoulos AD, Fletcher KE. A comparison of three family therapy programs for treating family conflicts in adolescents with attention-deficit hyperactivity disorder. J Consult Clin Psychol 1992;60:450-462. https://doi.org/10.1037/0022-006X.60.3.450
  260. Webster-Stratton C. The incredible years: a troubleshooting guide for parents of children aged 3-8. Toronto: Umbrella Press;1992.
  261. Kazdin AE. Parent management training: evidence, outcomes, and issues. J Am Acad Child Adolesc Psychiatry 1997;36:1349-1356. https://doi.org/10.1097/00004583-199710000-00016
  262. DuPaul GJ, Gormley MJ, Laracy SD. School-based interventions for elementary school students with ADHD. Child Adolesc Psychiatr Clin N Am 2014;23:687-697. https://doi.org/10.1016/j.chc.2014.05.003
  263. Gormley MJ, Dupaul GJ. Teacher-to-teacher consultation: facilitating consistent and effective intervention across grade levels for students with ADHD. Psychol Sch 2015;52:124-138. https://doi.org/10.1002/pits.21803
  264. Fabiano GA, Pelham Jr WE, Gnagy EM, Burrows-MacLean L, Coles EK, Chacko A, et al. The single and combined effects of multiple intensities of behavior modification and methylphenidate for children with attention deficit hyperactivity disorder in a classroom setting. Sch Psychol Rew 2007;36:195-216.
  265. Evans SW, Owens JS, Bunford N. Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol 2014;43:527-551. https://doi.org/10.1080/15374416.2013.850700
  266. Abikoff H, Gittelman R. Hyperactive children treated with stimulants. Is cognitive training a useful adjunct? Arch Gen Psychiatry 1985;42:953-961. https://doi.org/10.1001/archpsyc.1985.01790330033004
  267. Dush DM, Hirt ML, Schroeder HE. Self-statement modification in the treatment of child behavior disorders: a meta-analysis. Psychol Bull 1989;106:97-106. https://doi.org/10.1037/0033-2909.106.1.97
  268. Bear RA, Nietzel MT. Cognitive and behavioral treatment of impulsivity in children: a meta-analytic review of the outcome literature. J Clin Child Psychol 1991;20:400-412. https://doi.org/10.1207/s15374424jccp2004_9
  269. Bloomquist ML, August GJ, Ostrander R. Effects of a schoolbased cognitive-behavioral intervention for ADHD children. J Abnorm Child Psychol 1991;19:591-605. https://doi.org/10.1007/BF00925822
  270. Antshel KM, Faraone SV, Gordon M. Cognitive behavioral treatment outcomes in adolescent ADHD. J Atten Disord 2014;18:483-495. https://doi.org/10.1177/1087054712443155
  271. van de Weijer-Bergsma E, Formsma AR, de Bruin EI, Bogels SM. The effectiveness of mindfulness training on behavioral problems and attentional functioning in adolescents with ADHD. J Child Fam Stud 2012;21:775-787. https://doi.org/10.1007/s10826-011-9531-7
  272. Sibley MH, Pelham Jr WE, Derefinko KJ, Kuriyan AB, Sanchez F, Graziano PA. A pilot trial of supporting teens' academic needs daily (STAND): a parent-adolescent collaborative intervention for ADHD. J Psychopathol Behav Assess 2013;35:436-449. https://doi.org/10.1007/s10862-013-9353-6
  273. Fohlmann AH. Social skills training [Social færdighedstræning [Danish]]. In: Kjaer SK, Nordentoft M, Melau M, Iversen T, editors. Psykose hos unge. Copenhagen: Psykiatrifondens forlag; 2009.
  274. Jolles DD, Crone EA. Training the developing brain: a neurocognitive perspective. Front Hum Neurosci 2012;6:76.
  275. Willis SL, Schaie KW. Cognitive training and plasticity: theoretical perspective and methodological consequences. Restor Neurol Neurosci 2009;27:375-389.
  276. Karch D, Albers L, Renner G, Lichtenauer N, von Kries R. The efficacy of cognitive training programs in children and adolescents: a meta-analysis. Dtsch Arztebl Int 2013;110:643-652.
  277. Beauregard M, Levesque J. Functional magnetic resonance imaging investigation of the effects of neurofeedback training on the neural bases of selective attention and response inhibition in children with attention-deficit/hyperactivity disorder. Appl Psychophysiol Biofeedback 2006;31:3-20. https://doi.org/10.1007/s10484-006-9001-y
  278. Kim HL, Kim JW, Hong SB, Cho JH, Kim BN, Shin MS, et al. Effects of neurofeedback in children with attention deficit hyperactivity disorder: a preliminary study. J Korean Neuropsychiatr Assoc 2012;51:326-334. https://doi.org/10.4306/jknpa.2012.51.5.326
  279. Knouse LE, Safren SA. Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. Psychiatr Clin North Am 2010;33:497-509. https://doi.org/10.1016/j.psc.2010.04.001
  280. Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O, et al. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry 2009;50:780-789. https://doi.org/10.1111/j.1469-7610.2008.02033.x
  281. Kwon MS. Effects of neuro-feedback training including behaviour contract with ADHD. Seoul: Kyung Hee Univ.;2012.
  282. Roh OB, Son CN, Park TW, Park SK. The effects of neurofeedback training on inattention and hyperactivity/impulsivity in children with ADHD. Korean J Clin Psychol 2011;30:397-418. https://doi.org/10.15842/kjcp.2011.30.2.003
  283. Lansbergen MM, van Dongen-Boomsma M, Buitelaar JK, Slaats- Willemse D. ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study. J Neural Transm (Vienna) 2011;118:275-284. https://doi.org/10.1007/s00702-010-0524-2
  284. Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, et al. The prevalence and effects of adult attention deficit/ hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 2005;47:565- 572. https://doi.org/10.1097/01.jom.0000166863.33541.39
  285. Safren SA. Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 2006;67 Suppl 8:46-50.
  286. Young S, Amarasinghe JM. Practitioner review: non-pharmacological treatments for ADHD: a lifespan approach. J Child Psychol Psychiatry 2010;51:116-133. https://doi.org/10.1111/j.1469-7610.2009.02191.x
  287. Ramsay JR. Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2007;9:427-433. https://doi.org/10.1007/s11920-007-0056-0
  288. Drechsler R, Straub M, Doehnert M, Heinrich H, Steinhausen HC, Brandeis D. Controlled evaluation of a neurofeedback training of slow cortical potentials in children with attention deficit/hyperactivity disorder (ADHD). Behav Brain Funct 2007;3:35. https://doi.org/10.1186/1744-9081-3-35
  289. Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005;43:831-842. https://doi.org/10.1016/j.brat.2004.07.001
  290. Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010;167:958-968. https://doi.org/10.1176/appi.ajp.2009.09081123
  291. Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Curr Med Res Opin 2013;29:1093-1104. https://doi.org/10.1185/03007995.2013.812961
  292. Feldman HM, Reiff MI. Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents. N Engl J Med 2014; 370:838-846. https://doi.org/10.1056/NEJMcp1307215

Cited by

  1. The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (III) - Pharmacological Treatment - vol.28, pp.2, 2017, https://doi.org/10.5765/jkacap.2017.28.2.70
  2. Pharmacotherapy for attention-deficit/hyperactivity disorder vol.62, pp.1, 2019, https://doi.org/10.5124/jkma.2019.62.1.49
  3. Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder vol.31, pp.1, 2016, https://doi.org/10.5765/jkacap.190030
  4. ADHD 동물모델에서 가감청심연자탕의 효과에 관한 실험연구 vol.31, pp.3, 2016, https://doi.org/10.7231/jon.2020.31.3.149
  5. ADHD 동물모델에서 가감청심연자탕의 효과에 관한 실험연구 vol.31, pp.3, 2016, https://doi.org/10.7231/jon.2020.31.3.149
  6. Can the MMPI Predict Adult ADHD? An Approach Using Machine Learning Methods vol.11, pp.6, 2016, https://doi.org/10.3390/diagnostics11060976
  7. Effects of equine-assisted activities on attention and quality of life in children with cerebral palsy in a randomized trial: examining the comorbidity with attention-deficit/hyperactivity disorder vol.21, pp.1, 2016, https://doi.org/10.1186/s12887-021-02597-0